RSA
ABBV icon

River Street Advisors’s AbbVie ABBV Stock Holding History

River Street Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Buy
13,777
+205
+2% +$44.1K 1.02% 24
2026
Q1 		$2.95M Buy
13,572
+1,977
+17% +$439K 1% 28
2025
Q4 		$2.65M Sell
11,595
-154
-1% -$35.1K 0.99% 29
2025
Q3 		$2.72M Buy
11,749
+476
+4% +$96.9K 1.05% 28
2025
Q2 		$2.09M Sell
11,273
-59
-0.5% -$11K 0.9% 28
2025
Q1 		$2.37M Buy
11,332
+513
+5% +$99.7K 1.18% 22
2024
Q4 		$1.92M Buy
10,819
+224
+2% +$41.2K 0.98% 29
2024
Q3 		$2.09M Buy
10,595
+1,179
+13% +$220K 1.14% 23
2024
Q2 		$1.62M Buy
9,416
+1
+0% +$166 0.99% 29
2024
Q1 		$1.71M Buy
9,415
+24
+0.3% +$4.14K 1.16% 25
2023
Q4 		$1.46M Buy
9,391
+237
+3% +$34.6K 1.16% 22
2023
Q3 		$1.36M Buy
9,154
+236
+3% +$34.6K 1.29% 20
2023
Q2 		$1.2M Sell
8,918
-304
-3% -$44.6K 1.15% 22
2023
Q1 		$1.47M Buy
9,222
+153
+2% +$23.4K 1.45% 14
2022
Q4 		$1.47M Buy
+9,069
New +$1.39M 1.57% 12

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

River Street Advisors's ABBV Position: Q2 2026 in Review

River Street Advisors increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $44.1K and bringing the position to 13,777 shares worth $3.47M. The position accounts for 1.02% of the portfolio, ranked #24.

River Street Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • River Street Advisors held 13,777 shares of AbbVie worth $3.47M as of Q2 2026.
  • River Street Advisors bought 205 AbbVie shares in Q2 2026, an estimated $44.1K.
  • AbbVie made up 1.02% of River Street Advisors's portfolio in Q2 2026, its #24 holding.
  • River Street Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on River Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.